Mounjaro's generic and chemical names: what they mean for you

Step 1 (the international non-proprietary name is assigned before a medicine reaches patients

Every new medicine is given an International Non-proprietary Name) its INN, by the World Health Organisation during development, usually before it has a brand name at all. The INN is a precise, standardised label tied to the molecule's chemical identity. For this medicine, the WHO assigned the INN tirzepatide years before Eli Lilly finalised what to call it on pharmacy shelves.

Tirzepatide belongs to a class of molecules called GIP and GLP-1 receptor agonists. That dual action sets it apart from older GLP-1 medicines; it activates two separate gut-hormone pathways involved in appetite regulation and blood-sugar control. The INN captures none of that detail, it is simply a unique identifier, the same in every country, on every prescription, in every language. The BNF entry for tirzepatide uses this INN throughout, which is why your prescription and any dispensing label will carry the word "tirzepatide" whether or not "Mounjaro" appears alongside it.

A question our prescribers hear most weeks is some version of: "My prescription says tirzepatide, is that the same as Mounjaro?" Yes, entirely. The prescriber has written the INN, as good practice and UK guidance encourage, and the pharmacist then dispenses the licensed branded product, which, right now, is Mounjaro.

Step 2, Eli Lilly chose 'Mounjaro' as the UK brand name and sought MHRA approval

Once a medicine clears clinical trials and regulatory review, the manufacturer applies for a brand name alongside the marketing authorisation. In the UK, the MHRA grants that authorisation. Eli Lilly's chosen brand for tirzepatide in both the UK and the US is Mounjaro, though the regulatory environments (and therefore the licensed indications and approved doses) differ between countries.

In the UK, Mounjaro is licensed for weight management in adults with a body-mass index of 30 or above (or 27 or above with at least one weight-related health condition), and separately for type 2 diabetes. It carries a Black Triangle (▼) designation, meaning the MHRA requires additional post-marketing surveillance while long-term safety data continues to accumulate. You can read more about what that licence covers on our tirzepatide overview.

The NHS describes tirzepatide on its medicines pages and NICE evaluated it under the INN in its guidance, NICE technology appraisal TA1026, recommending it for eligible adults in phased NHS rollout, but the branded product those documents refer to is the same pen you'd receive privately through a regulated pharmacy.

Step 3, understanding why no 'generic Mounjaro' is legally available in the UK today

In everyday language, people often use "generic" to mean a cheaper, off-patent alternative to a branded medicine. That's not the same as the INN. The patent protecting Eli Lilly's tirzepatide formulation and manufacturing process has not expired; no other company has yet received MHRA authorisation to produce and sell a competing tirzepatide product in the UK. So while tirzepatide is the correct generic (INN) name for the medicine, there is currently no generic Mounjaro in the sense consumers usually mean, a separate, lower-cost licensed alternative. If you'd like a fuller explanation of what the Mounjaro generic name actually refers to, and how the INN and brand name relate to each other, that page sets it out clearly.

This distinction matters enormously for safety. Products marketed online as "generic tirzepatide" are not MHRA-authorised medicines. The MHRA has warned publicly about counterfeit and unlicensed weight-loss pens circulating through social media and unregulated websites, some found to contain entirely different substances. Buying from a GPhC-registered online pharmacy, which you can verify at the GPhC pharmacy register, is the only safe route. For more context on how Mounjaro's price is structured through legitimate UK providers, the Mounjaro cost and pricing page covers what to expect.

If you've been researching what "generic Mounjaro" actually means in practice, or have seen references to tirzepatide under other names, our guide to tirzepatide's various names breaks down every label in use, including overseas brand names that don't apply to the UK. The full Mounjaro information page is the place to start if you'd like to understand the medicine's evidence base before deciding whether to speak to a prescriber.

What the name on a prescription or packaging tells you, and what to check

When a UK prescriber writes tirzepatide on a prescription, they are using the INN. The dispensing pharmacist supplies Mounjaro, because that is the only MHRA-authorised tirzepatide product currently on the UK market. Both names should effectively point you to the same 2.5mg–15mg KwikPen format, manufactured by Eli Lilly and supplied through the licensed UK wholesale chain.

If a product reaches you labelled differently (using a brand name you don't recognise, claiming to be tirzepatide without the Mounjaro branding, or citing a foreign regulatory approval rather than the MHRA's) treat that as a serious red flag. Legitimate supply doesn't require unusual explanations about why the packaging looks different. You can also cross-reference the medicine against the NHS tirzepatide medicines page, which covers what the licensed product is, how it works, and what side effects to expect.

If you're thinking about starting treatment and want to understand whether you'd be eligible, you're welcome to check your eligibility with our prescribers. A real clinician reviews your consultation the same day (not software) and will only proceed if treatment is appropriate for you.